Diegeo overpaid for their last company they bought. They have a market cap 5x that of Constellation. The company only posted a slight growth last year and definitely wants in the cannabis infused market. Vivo is an attractive under the radar target that would be a great deal. Right now Vivo does not have growth output but that will change 10 fold soon.
And don't forget Vivo has two board members that were "shot callers" with Diegeo. I mean Diegeo executives.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.